Navigation Links
ANGIOTECH PHARMACEUTICALS ANNOUNCES CONFERENCE CALL AND WEBCAST
Date:10/13/2010

VANCOUVER, Oct. 13 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) will host a conference call discussing its financial results for the third quarter ended September 30, 2010, on Tuesday, November 9, 2010 at 11:00 AM ET (8:00 AM PT).

Dial-in information for the earnings call on November 9, 2010 is as follows: North America (toll-free): (800) 510-9834 International: (617) 614-3669 Enter Passcode: 9442 9774

A live webcast of the earnings call will be available to interested parties through Angiotech's website at www.angiotech.com in the Investors section.

A press release announcing Angiotech's financial results will be issued prior to the call on November 9th at approximately 8:00 AM ET (5:00 AM PT).

An archived replay of the call will be available until November 16, 2010.

Replay information is as follows: North America (toll-free): (888) 286-8010 International: (617) 801-6888 Enter Passcode: 4734 7778

About Angiotech Pharmaceuticals

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech (NASDAQ: ANPI, TSX: ANP), please visit our website at www.angiotech.com.


'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Angiotech Pharmaceuticals, Inc. Announces Commencement of Arbitration and Litigation Proceedings by QSR Holdings, Inc. Against the Company And Certain of Its Subsidiaries
2. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010
3. Angiotech Pharmaceuticals and partner Athersys announce positive results from phase I study of MultiStem(R) in heart attack patients
4. Angiotech Pharmaceuticals Announces Conference Call and Webcast
5. Angiotech announces exclusive distribution agreement with B. Braun for Angiotechs proprietary Quill(TM) SRS product line
6. Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2009
7. Angiotech Pharmaceuticals Announces Conference Call and Webcast
8. Angiotech Pharmaceuticals, Inc. Announces Conference Call and Webcast
9. Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States
10. Angiotech receives approval for Quill(TM) SRS PDO, MONODERM(TM), Polypropylene and Nylon product lines for sale in Brazil
11. Angiotechs Licensee, Cook Medical, Announces CE Mark Approval and European Launch of the Zilver(R) PTX(R) Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... ... February 20, 2017 , ... Cancer diagnostics and ... Oncology™” (Crosswalk), a unique precision medicine knowledge visualization and decision support platform. ... Inspirata’s diagnostic cockpit and is downloadable as an app for any mobile device ...
(Date:2/20/2017)... , ... February 20, 2017 ... ... therapeutic success among radiotherapy patients, prevent chest wall collapses in pre-term infants ... alignments will receive a total of $600,000 in funding through the ninth ...
(Date:2/20/2017)... NFL players who had repeated head injuries may not have ... a preliminary study released today that will be presented at ... Boston , April 22 to 28, 2017.   ... and nerves work together, like walking, kicking and writing. ... Repeated head ...
(Date:2/20/2017)... Fla. , Feb. 20, 2017  Atrius Health ... today entered into an agreement to develop a ... experience. By providing a holistic view of the ... determinants, Watson Cognitive Insights could be designed to ... Atrius Health is an innovative nonprofit healthcare organization ...
Breaking Biology Technology:
(Date:2/21/2017)... Der weltweite Biobanking-Sektor wird bis ... Gespräch mit mehr als 50 Vertretern aus verschiedenen Branchen wurde ... um diese Prognose zu realisieren. ... Zu den Schwierigkeiten ... Mittel für die Biobank, die Implementierung Zeit sparender Technologien, ...
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist Medical ... its new chief executive officer (CEO). Freischlag joins the ... John D. McConnell , M.D., who last year announced ... the Medical Center, after leading it since 2008.   ... scope of Wake Forest Baptist,s academic health system, which ...
(Date:2/13/2017)... , Feb. 13, 2017 Former 9/11 Commission ... Judiciary Committee, Janice Kephart of Identity Strategy ... Donald Trump,s "Executive Order: Protecting the Nation ... 27, 2017):  "As President Trump,s ,Travel Ban, ... has now essentially banned the travel ban, it is ...
Breaking Biology News(10 mins):